2,5-bis[4-(4-pentylphenyl)triazol-1-yl]benzimidazolo[1,2-a]quinoline-6-carbonitrile
C42H39N9 — CID 155560568
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2,5-bis[4-(4-pentylphenyl)triazol-1-yl]benzimidazolo[1,2-a]quinoline-6-carbonitrile
2,5-bis[4-(4-pentylphenyl)triazol-1-yl]benzimidazolo[1,2-a]quinoline-6-carbonitrile (PubChem CID 155560568) has the molecular formula C42H39N9 and a molecular weight of 669.84 g/mol. Its IUPAC name is 2,5-bis[4-(4-pentylphenyl)triazol-1-yl]benzimidazolo[1,2-a]quinoline-6-carbonitrile.
Molecular Properties
| Compound Name | 2,5-bis[4-(4-pentylphenyl)triazol-1-yl]benzimidazolo[1,2-a]quinoline-6-carbonitrile |
|---|---|
| PubChem CID | 155560568 |
| Molecular Formula | C42H39N9 |
| Molecular Weight | 669.84 g/mol |
| Exact Mass | 669.33 |
| IUPAC Name | 2,5-bis[4-(4-pentylphenyl)triazol-1-yl]benzimidazolo[1,2-a]quinoline-6-carbonitrile |
| SMILES | CCCCCc1ccc(-c2cn(-c3ccc4c(-n5cc(-c6ccc(CCCCC)cc6)nn5)c(C#N)c5nc6ccccc6n5c4c3)nn2)cc1 |
| InChI | InChI=1S/C42H39N9/c1-3-5-7-11-29-15-19-31(20-16-29)37-27-49(47-45-37)33-23-24-34-40(25-33)51-39-14-10-9-13-36(39)44-42(51)35(26-43)41(34)50-28-38(46-48-50)32-21-17-30(18-22-32)12-8-6-4-2/h9-10,13-25,27-28H,3-8,11-12H2,1-2H3 |
| InChIKey | KBJUEFIMFBKSSJ-UHFFFAOYSA-N |
| XLogP | 9.47 |
| TPSA | 102.51 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 51 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 669.84 |
| LogP ≤ 5 | 9.47 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 9 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155560568 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.